Beximco Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 5/6
Beximco Pharmaceuticals is a dividend paying company with a current yield of 4.94% that is well covered by earnings.
Key information
4.9%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 10.2% |
| Dividend Growth | 14.0% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | UK£0.0335 |
| Payout ratio | 30% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: BXP's dividends per share have been stable in the past 10 years.
Growing Dividend: BXP's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
| Beximco Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BXP) | 4.9% |
| Market Bottom 25% (GB) | 2.1% |
| Market Top 25% (GB) | 5.9% |
| Industry Average (Pharmaceuticals) | 2.5% |
| Analyst forecast (BXP) (up to 3 years) | 10.2% |
Notable Dividend: BXP's dividend (4.94%) is higher than the bottom 25% of dividend payers in the UK market (2.11%).
High Dividend: BXP's dividend (4.94%) is low compared to the top 25% of dividend payers in the UK market (5.87%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (30%), BXP's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its reasonably low cash payout ratio (33.1%), BXP's dividend payments are well covered by cash flows.